Showing results (361-370 of 468) with videos related to

Sort By:
Pageof 47
Journal of Proteomics|August 1, 2012
Analysis of serum total and free PSA using immunoaffinity depletion coupled to SRM: correlation with clinical immunoassay testsTao Liu, Mahmud Hossain, Athena A Schepmoes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 15, 2023
Association of Molecular Subtypes with Pathologic Response, PFS, and OS in a Phase II Study of COXEN with Neoadjuvant Chemotherapy for Muscle-invasive Bladder CancerSeth P Lerner, David J McConkey, Catherine M Tangen, et al.
The Journal of Urology|April 22, 2014
High prevalence of screen detected prostate cancer in West Africans: implications for racial disparity of prostate cancerAnn W Hsing, Edward Yeboah, Richard Biritwum, et al.
The New England Journal of Medicine|June 26, 2003
The influence of finasteride on the development of prostate cancerIan M Thompson, Phyllis J Goodman, Catherine M Tangen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2006
Selenium accumulation in prostate tissue during a randomized, controlled short-term trial of l-selenomethionine: a Southwest Oncology Group StudyAnita L Sabichi, J Jack Lee, Robert J Taylor, et al.
The Journal of Urology|August 5, 2018
Continued 5α-Reductase Inhibitor Use after Prostate Cancer Diagnosis and the Risk of Reclassification and Adverse Pathological Outcomes in the PASSJames T Kearns, Anna V Faino, Jeanette M Schenk, et al.
JAMA Oncology|August 28, 2020
Tailoring Intensity of Active Surveillance for Low-Risk Prostate Cancer Based on Individualized Prediction of Risk StabilityMatthew R Cooperberg, Yingye Zheng, Anna V Faino, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2021
A Randomized Phase II Study of Coexpression Extrapolation (COXEN) with Neoadjuvant Chemotherapy for Bladder Cancer (SWOG S1314; NCT02177695)Thomas W Flaig, Catherine M Tangen, Siamak Daneshmand, et al.
Journal of the National Cancer Institute|September 13, 2007
Finasteride and high-grade prostate cancer in the Prostate Cancer Prevention TrialM Scott Lucia, Jonathan I Epstein, Phyllis J Goodman, et al.
JU Open Plus|February 19, 2026
Combining Serum Prostate Health Index With Urinary PCA3 and TMPRSS2:ERG RNA Testing Improves Detection of Clinically Significant Prostate CancerNicholas W Eyrich, Yijian Huang, Yingye Zheng, et al.
Pageof 47